These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15685026)

  • 21. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
    Thurfjell EL; Lindgren JA
    Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not everyone agrees with new mammographic screening guidelines designed to end confusion.
    King AS
    JAMA; 1989 Sep; 262(9):1154-5. PubMed ID: 2761049
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast cancer screening. Interpreting new data for clinical practice.
    Daly L
    Physician Assist; 1994 Oct; 18(10):47-51, 56, 61-6. PubMed ID: 10138304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass mammographic screening--the other side of the argument.
    Liddell MJ
    Aust Fam Physician; 1993 Jul; 22(7):1168-75. PubMed ID: 8123107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic screening: does it work?
    Handler S
    Minn Med; 2003 Dec; 86(12):6-7. PubMed ID: 14719608
    [No Abstract]   [Full Text] [Related]  

  • 26. [The National Board of Health and Welfare on mammographic screening: mortality analysis requires completely different methods].
    Rehnqvist N; Rosén M; Karlberg I
    Lakartidningen; 1999 Mar; 96(9):1050-1. PubMed ID: 10093453
    [No Abstract]   [Full Text] [Related]  

  • 27. Mammographic screening and "overdiagnosis".
    Kopans DB; Smith RA; Duffy SW
    Radiology; 2011 Sep; 260(3):616-20. PubMed ID: 21846757
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer detection: improving the efficacy of screening mammography.
    Brecheisen NL; Snyder TE
    Kans Med; 1994 Apr; 95(4):90-3. PubMed ID: 8041052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased breast cancer mortality through mammographic screening: results of clinical trials.
    Feig SA
    Radiology; 1988 Jun; 167(3):659-65. PubMed ID: 3283836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The benefits and risks of mammographic screening for breast cancer.
    Hurley SF; Kaldor JM
    Epidemiol Rev; 1992; 14():101-30. PubMed ID: 1289109
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Lancet supports Danish researchers against the breast cancer group. Mammographic screening causes a conflict within Cochrane].
    Ohlin E
    Ugeskr Laeger; 2001 Nov; 163(48):6769. PubMed ID: 11768908
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast cancer screening by mammography: an overview.
    Cuckle H
    Clin Radiol; 1991 Feb; 43(2):77-80. PubMed ID: 2004517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Make an independent assessment of mammographic screening!].
    Einhorn J
    Lakartidningen; 2000 Mar; 97(12):1366-7. PubMed ID: 10765617
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluating the benefits of mammographic breast cancer screening].
    Kullmann T; Misset JL
    Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of mammographic screening on breast cancer diagnosis.
    McWhorter WP; Eyre HJ
    J Natl Cancer Inst; 1990 Jan; 82(2):153. PubMed ID: 2294227
    [No Abstract]   [Full Text] [Related]  

  • 38. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?
    Jørgensen KJ; Keen JD; Gøtzsche PC
    Radiology; 2011 Sep; 260(3):621-7. PubMed ID: 21846758
    [No Abstract]   [Full Text] [Related]  

  • 39. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammographic screening for women aged 40 to 49 years: the primary care practitioner's dilemma.
    Sickles EA; Kopans DB
    Ann Intern Med; 1995 Apr; 122(7):534-8. PubMed ID: 7872590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.